Article
First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.
PloS one - 1 Jan 2014
Goo Youn-Kyoung, Ji So-Young, Shin Hyun-Il, Moon Jun-Hye, Cho Shin-Hyung, Lee Won-Ja, Kim Jung-Yeon
Abstract excerpt
BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect and affects more than 400 million people worldwide. This deficiency is believed to protect against malaria because its global distribution is similar. However, this genetic disorder may be associated with potential hemolytic anemia after treatment with anti-malarials, primaquine or other 8-aminoquinolines....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
